Unknown

Dataset Information

0

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.


ABSTRACT: We have developed a theranostic nanoparticle, ie, cet-PEG-dexSPIONs, by conjugation of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody, cetuximab, to dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) via periodate oxidation. Approximately 31 antibody molecules were conjugated to each nanoparticle. Cet-PEG-dexSPIONs specifically bind to EGFR-expressing tumor cells and enhance image contrast on magnetic resonance imaging. Cet-PEG-dexSPION-treated A431 cells showed significant inhibition of epidermal growth factor-induced EGFR phosphorylation and enhancement of EGFR internalization and degradation. In addition, a significant increase in apoptosis was detected in EGFR-overexpressing cell lines, A431 and 32D/EGFR, after 24 hours of incubation at 37°C with cet-PEG-dexSPIONs compared with cetuximab alone. The antibody-dependent cell-mediated cytotoxicity of cetuximab was observed in cet-PEG-dexSPIONs. The results demonstrated that cet-PEG-dexSPIONs retained the therapeutic effect of cetuximab in addition to having the ability to target and image EGFR-expressing tumors. Cet-PEG-dexSPIONs represent a promising targeted magnetic probe for early detection and treatment of EGFR-expressing tumor cells.

SUBMITTER: Tseng SH 

PROVIDER: S-EPMC4445874 | biostudies-other | 2015

REPOSITORIES: biostudies-other

altmetric image

Publications

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.

Tseng Shih-Heng SH   Chou Min-Yuan MY   Chu I-Ming IM  

International journal of nanomedicine 20150520


We have developed a theranostic nanoparticle, ie, cet-PEG-dexSPIONs, by conjugation of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody, cetuximab, to dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) via periodate oxidation. Approximately 31 antibody molecules were conjugated to each nanoparticle. Cet-PEG-dexSPIONs specifically bind to EGFR-expressing tumor cells and enhance image contrast on magnetic resonance imaging. Cet-PEG-dexSPION-treated A431 cells sh  ...[more]

Similar Datasets

| S-EPMC4496184 | biostudies-literature
| S-EPMC4727823 | biostudies-literature
| S-EPMC3577933 | biostudies-literature
| S-EPMC8240647 | biostudies-literature
| S-EPMC2912981 | biostudies-other
| S-EPMC3794963 | biostudies-literature
| S-EPMC5105135 | biostudies-literature
| S-EPMC7435411 | biostudies-literature
| S-EPMC6365181 | biostudies-literature
| S-EPMC8400017 | biostudies-literature